Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effective dose of ciprofol for inhibiting responses to artificial airway insertion in different genders
ChiCTR2200061309Phase 4Recruiting
- Sponsor
- The First Affiliated Hospital of Zhengzhou University
- Start
- Jul 2022
- Modality
- Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of ciprofol in general anesthesia (2 arms), sponsored by The First Affiliated Hospital of Zhengzhou University. Primary endpoints: blood pressure, heart rate and 3 more. Started Jul 2022; status: recruiting.
02
Drugs
ciprofol
03
Conditions
general anesthesia
Beyond the preview
Go deeper on ChiCTR2200061309.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200061309.